Meet the 2026 Probiota Pioneers: ClostraBio, Holobiome and Kioga
NutraIngredients is pleased to announce Clostrabio, Holobiome and Kioga as the next Probiota Pioneers.
Archives for May 6, 2026
NutraWomen Wednesday: Amy McKelvey, founder of Her Vital Way
Amy McKelvey founded Her Vital Way to bring a personal and purpose-driven approach to wellness rooted in herbalism and consumer connection.
RTC: 5-MTHF matches folic acid while lowering unmetabolized folic acid in prenatal vitamins
Despite folic acid remaining the recommended form for early pregnancy, manufacturers are increasingly turning to 5-MTHF as questions persist about excess intake and metabolism.
Microbiome Explorer Challenge returns seeking Europe’s next microbiome start-up stars
The Microbiome Explorer Challenge, back for its second year, is offering successful early-stage startups the opportunity of expert mentorship, strategic feedback, industry visibility, and funding opportunities within the European microbiome innovation...
聚焦日本：功能性蛋白质、女性消费者健康关注点及更多内容
了解日本保健品市场的最新发展，包括功能性蛋白质领域的增长、女性消费者的健康关注点、最新研究发现等更多内容。
趋势追踪：印度蛋白质热潮、能量饮品、中国企业全球扩张
在本期新闻综述中，了解更多关于印度蛋白质消费热潮、中国能量饮料消费，以及中国企业如何加速海外市场扩张的信息。
科学短报：生姜提取物减重、南非醉茄增强运动能力及更多研究
本篇资讯重点介绍最新的健康与营养研究，包括关于蒸制生姜提取物减重、南非醉茄提升心肺适能等方面的新发现。
监管动态：穿心莲、咖啡因警示、生物制剂最新资讯
澳大利亚拟将穿心莲移出低风险原料目录、澳新地区运动食品需增设咖啡因标签警示，以及欧洲生物制剂法规更新，是本期监管资讯合集里的几项最新动态。
聚焦中国：BioGaia、功能性饮料需求、零售格局变化及更多资讯
本期综述涵盖多方面新闻，包括 BioGaia 的益生菌口腔健康补充剂、中国功能性饮料需求、零售格局变化、最新研究发现等。
Aussie discount pharmacy chain Chemist Warehouse to set foot in the UK
Chemist Warehouse has set its sights on the UK market and is working with London-based GreenLight pharmacies to do so.
China focus: BioGaia, functional drinks demand, shifts in retail landscape and more
This round-up looks at news including BioGaia’s probiotic oral health supplement, demand for functional drinks in China, shifts in retail landscape, latest research findings, and more.
HMO infant formulas: Regulatory developments to drive NPD and affordability
The growing number of regulatory approvals for human milk oligosaccharides (HMOs) in infant formulas is set to fuel product innovation and drive more affordable pricing in the long run.